Glycomics Market Growth and Forecast by 2028

[Research Report] The glycomics market is expected to grow from US$ 1,340.80 million in 2021 to US$ 3,223.30 million by 2028; it is estimated to grow at a CAGR of 13.4% from 2022 to 2028. 

Glycans are responsible for much of the structural variation in biologic systems, and their representation on cell surfaces is commonly called the “glycome.” Glycomics is an emerging field that aims to focus on the structure and function of glycans in a cell, tissue, or organism. Glycans are chain-like structures of carbohydrates that are free or conjugated to macromolecules such as lipids or proteins. They contribute to a diverse selection of biological processes such as protein folding, cell signaling, and immune recognition. These are implicated in several diseases such as oncological, autoimmune, and others. The glycomics market is being driven by increased glycomics research, a rise in R&D investments, and the use of glycomics to treat various diseases, leading to the development of new treatment processes. However, high equipment costs and a shortage of skilled professionals hinder the overall market growth.

The report offers insights and in-depth analysis of the glycomics market, emphasizing various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of global leading market players. It also includes the impact of the COVID-19 pandemic on the market across all regions. Due to the COVID-19 pandemic, many health authorities focused on pandemic-related care. Recently, more studies on coronavirus have uncovered infection mechanisms that rely on the virus using human glycans. For instance, GlycoNet researchers demonstrated that the COVID-19 virus enters cells by binding to glycolipids. Researchers are now testing whether COVID-19 variants of concern are changing their glycan-binding properties. Thus, the COVID-19 pandemic impacted the glycomics market positively due to the increased research worldwide.

Glycomics Market: Strategic Insights

Geography-Based Insights

By geography, the glycomics market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of the MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Market Insights

Rising Use of Glycomics in Various Diseases Leading to Development of New Treatment Processes

As scientists have concentrated their efforts in the glycomics field, they have started to learn important details about the functions of glycans and glycosylation in the body, including cellular communication and what these factors might reveal about disease development and diagnostics. The largest and fastest-growing application category is drug discovery and development, mostly due to the rise in R&D by pharmaceutical and biotechnology firms and the expansion of drug discovery research activities in university research institutions. For instance, in April 2020, to commercialize a cutting-edge cancer detection tool, researchers from the Institute for Glycomics and the University of Adelaide signed an exclusive licensing agreement with Sienna Cancer Diagnostics Ltd. These researchers have created a special protein called SubB2M, which attaches exclusively to a sugar molecule, only found in cancer cells. This protein might revolutionize the detection of cancer. In addition, in January 2022, The National Health and Medical Research Council (NHMRC) gave researchers from the Institute of Glycomics grants totaling more than US$ 1,100,000 million to help them create new medicines to treat multidrug-resistant gonorrhea infections.

Product-Based Insights

Based on product, the global glycomics market is segmented into enzymes, instruments, kits, and reagents. In 2021, the enzymes segment would account for the largest share of the market; it is further expected to register the highest CAGR in the glycomics market from 2022 to 2028. 

Application-Based Insights

Based on application, the global glycomics market is segmented into drug discovery and development, diagnostics, immunology, cancer, and others. The drug discovery and development segment would hold the largest share of the market in 2021. However, the diagnostics segment is anticipated to grow at the highest CAGR during the forecast period. The major driving factors for the application segment are increasing research on orphan and rare diseases, rising need for drug development, and growing awareness about early diagnosis.

The regional trends and factors influencing the Glycomics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Glycomics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Glycomics Market Report Scope

Glycomics Market Players Density: Understanding Its Impact on Business Dynamics

The Glycomics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

End User-Based Insights

Based on end user, the global glycomics market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. The pharmaceutical and biotechnology companies’ segment would hold the largest market share in 2021, and the same segment is expected to grow at the highest CAGR during the forecast period.

The glycomics market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide and meet the growing demand. Some major players contributing to the glycomics market are Merck KGaA; Agilent Technologies, Inc.; New England Biolabs; Thermo Fisher Scientific Inc.; Waters Corporation; Asparia Glycomics; Bruker Corporation; Takara Bio Inc.; S-BIO; and Shimadzu Corporation, among others.